Press release
TurboGen Advances in the American Market: Signs LOI for System Installation with New US Client
September 4, 2024 - TurboGen (TASE: TURB), a leader in developing advanced solutions for local energy production, is pleased to announce today that it has signed a letter of intent (LOI) with a US client for the supply and installation of the company's micro-turbine systems (one or more) to generate energy for the client's facilities. The LOI, signed on September 2, 2024, represents a significant step in expanding the company's operations in the US market and in promoting TurboGen's innovative "Energy as a Service" model.Yaron Gilboa, CEO of TurboGen: "The signing of this LOI marks another significant milestone in our global expansion. The growing demand for efficient and sustainable energy solutions in the US market underscores the need for TurboGen's technology. We believe that our 'Energy as a Service' model will allow customers to benefit from our technology while reducing costs and increasing energy efficiency."
This announcement follows a number of TurboGen's recent successes, including the first installation of a commercial system in New York City and the completion of successful trials at Technion laboratories, confirming the hydrogen combustion capabilities of the company's systems.
About TurboGen:
TurboGen (TASE: TURB) specializes in developing advanced solutions for local energy production in buildings and various facilities. The company's innovative technology is designed to provide efficient, reliable, and environmentally friendly energy solutions, addressing the growing global demand for distributed electricity generation.
For more information about the company: https://turbogenchp.com
This press release may contain forward-looking statements. Forward-looking statements describe future expectations, plans, results, or strategies (including product offerings, regulatory plans and business plans) and may change without notice. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements.
Media Contact
Company Name: TurboGen
Contact Person: Investor Relations
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=turbogen-advances-in-the-american-market-signs-loi-for-system-installation-with-new-us-client]
City: Petah Tikva
Country: Israel
Website: http://turbogenchp.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release TurboGen Advances in the American Market: Signs LOI for System Installation with New US Client here
News-ID: 3645346 • Views: …
More Releases from ABNewswire
The Life and Loves of an Artist Illuminates the Remarkable Journey Behind a Life …
Authors Paul and Gail King present The Life and Loves of an Artist. This sweeping biographical narrative traces the extraordinary story of a family whose lives were intertwined with art, resilience, and history.
Rooted in meticulous research and personal reflection, the book offers a moving portrait of two generations shaped by both hardship and inspiration.
Purpose of the Book
What started as an attempt to remember family memories became a vivid journey of…
Alzheimer's Disease Market in the 7MM is projected to reach USD 34 Billion by 20 …
Key players operating in the Alzheimer's disease market include Eisai, Biogen, Changchun Huayang High-tech Co. Ltd., Hoffmann-La Roche, vTv Therapeutics, AZTherapies, Cerecin, Neurotrope, Lyndra, AC Immune, INmune Bio, Cassava Sciences, EIP Pharma, Neuraly, AB Science, Cortexyme, Anavex Life Sciences, Athira Pharma, Time Therapeutics, Prilenia Therapeutics, Denali Therapeutics Inc., Stemedica Cell Technologies, Inc., along with several other emerging and established companies.
The Alzheimer's disease market was valued at approximately USD 3,610 million…
Glaucoma Market Forecast 2034: USD 4,073 Million Market Size, 30+ Companies, and …
Major Glaucoma players include Allergan (AbbVie), Sun Pharma Advanced Research Company Limited, Santen Pharmaceutical Co., Ltd., Alcon, D. Western Therapeutics Institute (DWTI), Kowa Ltd., Senju Pharmaceuticals, Otsuka Pharmaceuticals, Bausch and Lomb, Novartis, Merck & Co., Aerie Pharmaceuticals, Nicox Ophthalmics, Sylentis, Envisia Therapeutics, Ocuphire Pharma, TearClear, Peregrine Ophthalmic, and others.
The Glaucoma Market across the seven major markets (7MM) - the United States, EU4 (Germany, France, Italy, and Spain), the United Kingdom,…
Graves' Disease Market Size in the 7MM was ~USD 4,400 million in 2023 and is exp …
DelveInsight's "Graves' Disease Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Graves' Disease, historical and forecasted epidemiology as well as the Graves' Disease market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
Explore Graves' Disease Market Trends, treatment landscapes, and emerging therapies shaping the future. Download sample report @ [https://www.delveinsight.com/sample-request/graves-disease-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Key Takeaways from the Graves' Disease Market Report
* In December…
More Releases for TurboGen
TurboGen Collaborates on Developing a Mobile Energy Production System for the De …
TurboGen's entry into the defense industry highlights the technological relevance of its innovative solutions.
November 19, 2024 - TurboGen (TASE: TURB) (OTCPK: TURG.F), a leader in developing advanced innovative solutions for local energy production, is pleased to announce [https://www.linkedin.com/feed/update/urn:li:activity:7264610147996454916] the signing of a Memorandum of Understanding (MOU) with a leading Israeli defense company. The agreement, signed on November 19th 2024, focuses on integrating TurboGen's cutting-edge technology into a portable energy production…
TurboGen Advances in the European Market: Signs LOI for System Installation with …
This agreement represents a significant step in TurboGen's expansion into the European market and the German Market specifically, and in advancing TurboGen's innovative "Energy as a Service" model.
November 11, 2024 - TurboGen (TASE: TURB) (OTCPK: TURG.F), a leader in developing advanced innovative solutions for local energy production, is pleased to announce [https://turbogenchp.com/wp-content/uploads/2024/11/%D7%98%D7%95%D7%A8%D7%91%D7%95%D7%92%D7%9F-%D7%9E%D7%95%D7%A0%D7%92%D7%A9.pdf] today that it has entered into a Letter of Intent (LOI) with the Gemran Company 'IP Innovative Power…
Following its first commercial success, Groundbreaking trials at Technion Labora …
Petah Tikva, Israel - May 27th, 2024 - TurboGen (TASE: TURB), a leading developer of multi-fuel hybrid micro-turbines, is thrilled to announce that following the successful deployment of its first commercial installation, a series of groundbreaking tests conducted at the Technion Institute of Technology have provided scientific validation of the company's TG40 system's ability to operate efficiently and with high performance on hydrogen-methane fuel blends.
The trials, conducted under the supervision…
TurboGen Achieves Breakthrough with First Commercial System Now Operating in New …
PETAH TIKVA, Israel - May 08, 2024 - TurboGen (TASE: TURB), a leading developer of advanced solutions for on-site energy generation in residential buildings, Nursery Home, Hotels and facilities, today announced a significant milestone with the successful installation and commissioning of its first commercial system at a customer site in New York City. The groundbreaking TG40 system has been successfully integrated into the multi-story building's infrastructure, providing electricity and heat…
Industry Update: Fueling the Future - Israel's Hydrogen Ecosystem and the Path t …
As the world strides toward a greener future, Israel's hydrogen ecosystem is setting the stage for a monumental shift in global energy paradigms, with companies like TurboGen at the forefront, revolutionizing how we harness and utilize hydrogen power.
In the global race towards a sustainable future, Israel emerges as a frontrunner, charting a course through the uncharted waters of hydrogen innovation. The nation's unique blend of cutting-edge research, robust government support,…
